{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:36Z","timestamp":1791897816654,"version":"4.3.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inhaled nitric oxide (iNO), a selective pulmonary vasodilator, is used as a therapeutic modality in infants with hypoxemic respiratory failure (HRF) associated with persistent pulmonary hypertension of the newborn (PPHN). iNO should ideally be initiated following echocardiographic confirmation of PPHN. Use of iNO is recommended in late preterm and term infants who develop HRF despite optimal oxygenation and ventilation strategies. However, routine iNO use in preterm infants on respiratory support is not recommended. iNO may be considered as a rescue modality in preterm infants with early-onset HRF when associated with prolonged rupture of membranes or oligohydramnios, or late-onset HRF in the context of bronchopulmonary dysplasia-associated pulmonary hypertension (PH) with severe right ventricular failure. A trial of iNO may also be considered for infants with congenital diaphragmatic hernia with persistent HRF despite optimal lung recruitment, and with echocardiographic evidence of supra-systemic PH and adequate left ventricular function.<\/jats:p>","DOI":"10.1093\/pch\/pxac107","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:26:55Z","timestamp":1683174415000},"page":"119-122","source":"Crossref","is-referenced-by-count":17,"title":["Inhaled nitric oxide use in newborns"],"prefix":"10.1093","volume":"28","author":[{"given":"Souvik","family":"Mitra","sequence":"first","affiliation":[{"name":"Canadian Paediatric Society, Fetus and Newborn Committee , Ottawa, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Altit","sequence":"additional","affiliation":[{"name":"Canadian Paediatric Society, Fetus and Newborn Committee , Ottawa, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"2023050404264849600_CIT0001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0140-6736(92)92687-B","article-title":"Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Kinsella","year":"1992","journal-title":"Lancet"},{"key":"2023050404264849600_CIT0002","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study Group.","year":"1997","journal-title":"N Engl J Med"},{"key":"2023050404264849600_CIT0003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn","volume":"336","author":"Roberts","year":"1997","journal-title":"N Engl J Med"},{"key":"2023050404264849600_CIT0004","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/pch\/17.2.95","article-title":"Canadian Paediatric Society, Fetus and Newborn Committee. Inhaled nitric oxide use in newborns","volume":"17","author":"Peliowski","year":"2012","journal-title":"Paediatr Child Health"},{"key":"2023050404264849600_CIT0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"2023050404264849600_CIT0006","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.91.16.7583","article-title":"Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase","volume":"91","author":"Archer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023050404264849600_CIT0007","doi-asserted-by":"crossref","first-page":"e191179","DOI":"10.1001\/jamanetworkopen.2019.1179","article-title":"Evaluation of oxygen saturation index compared with oxygenation index in neonates with hypoxemic respiratory failure","volume":"2","author":"Muniraman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023050404264849600_CIT0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/apa.14958","article-title":"The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport","volume":"109","author":"Garrido","year":"2020","journal-title":"Acta Paediatr"},{"key":"2023050404264849600_CIT0009","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.113.3.559","article-title":"A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure","volume":"113","author":"Konduri","year":"2004","journal-title":"Pediatrics"},{"key":"2023050404264849600_CIT0010","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2023050404264849600_CIT0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa043927","article-title":"Inhaled nitric oxide for premature infants with severe respiratory failure","volume":"353","author":"Van Meurs","year":"2005","journal-title":"N Engl J Med"},{"key":"2023050404264849600_CIT0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jpc.14580","article-title":"Impact of inhaled nitric oxide stewardship programme in a neonatal intensive care unit","volume":"56","author":"Ahearn","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"2023050404264849600_CIT0013","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/hpeds.2016-0003","article-title":"Impact of stewardship on inhaled nitric oxide utilization in a neonatal ICU","volume":"6","author":"Elmekkawi","year":"2016","journal-title":"Hosp Pediatr"},{"key":"2023050404264849600_CIT0014","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1542\/peds.103.3.610","article-title":"Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia","volume":"103","author":"Banks","year":"1999","journal-title":"Pediatrics"},{"key":"2023050404264849600_CIT0015","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2023050404264849600_CIT0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1542\/peds.104.2.231","article-title":"Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn","volume":"104","author":"Davidson","year":"1999","journal-title":"Pediatrics"},{"key":"2023050404264849600_CIT0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1289\/ehp.8773201","article-title":"Biotransformation of nitric oxide","volume":"73","author":"Yoshida","year":"1987","journal-title":"Environ Health Perspect"},{"key":"2023050404264849600_CIT0018","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/apa.14436","article-title":"Treatment with nitric oxide in the neonatal intensive care unit is associated with increased risk of childhood cancer","volume":"107","author":"Dixon","year":"2018","journal-title":"Acta Paediatr"},{"key":"2023050404264849600_CIT0019","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2019.10.063","article-title":"Just Say No to iNO in Preterms\u2014Really?","volume":"218","author":"Lakshminrusimha","year":"2020","journal-title":"J Pediatr"},{"key":"2023050404264849600_CIT0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.semperi.2016.05.007","article-title":"Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant","volume":"40","author":"Sokol","year":"2016","journal-title":"Semin Perinatol"},{"key":"2023050404264849600_CIT0021","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0036-1571329","article-title":"Trends and variations in the use of inhaled nitric oxide in preterm infants in Canadian neonatal intensive care units","volume":"33","author":"Soraisham","year":"2016","journal-title":"Am J Perinatol"},{"key":"2023050404264849600_CIT0022","doi-asserted-by":"crossref","first-page":"e20193318","DOI":"10.1542\/peds.2019-3318","article-title":"Early hypoxic respiratory failure in extreme prematurity: Mortality and neurodevelopmental outcomes","volume":"146","author":"Chandrasekharan","year":"2020","journal-title":"Pediatrics"},{"key":"2023050404264849600_CIT0023","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41372-018-0131-x","article-title":"Outcomes of hypoxic respiratory failure at birth associated with previable rupture of membranes","volume":"38","author":"Baczynski","year":"2018","journal-title":"J Perinatol"},{"key":"2023050404264849600_CIT0024","first-page":"428","article-title":"Early use of inhaled nitric oxide in preterm infants: Is there a rationale for selective approach?","volume":"34","author":"Chandrasekharan","year":"2017","journal-title":"Am J Perinatol"},{"key":"2023050404264849600_CIT0025","doi-asserted-by":"crossref","first-page":"e180761","DOI":"10.1001\/jamapediatrics.2018.0761","article-title":"Association of early inhaled nitric oxide with the survival of preterm neonates with pulmonary hypoplasia","volume":"172","author":"Ellsworth","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2023050404264849600_CIT0026","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2023050404264849600_CIT0027","doi-asserted-by":"crossref","first-page":"e14690","DOI":"10.14814\/phy2.14690","article-title":"Assessing pulmonary circulation in severe bronchopulmonary dysplasia using functional echocardiography","volume":"9","author":"Sehgal","year":"2021","journal-title":"Physiol Rep"},{"key":"2023050404264849600_CIT0028","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"2023050404264849600_CIT0029","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/jamapediatrics.2016.2023","article-title":"Evaluation of variability in inhaled nitric oxide use and pulmonary hypertension in patients with congenital diaphragmatic hernia","volume":"170","author":"Putnam","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2023050404264849600_CIT0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpeds.2019.09.052","article-title":"Inhaled nitric oxide is associated with improved oxygenation in a subpopulation of infants with congenital diaphragmatic hernia and pulmonary hypertension","volume":"219","author":"Lawrence","year":"2020","journal-title":"J Pediatr"}],"container-title":["Paediatrics &amp; Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/28\/2\/119\/50193576\/pxac107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pch\/article-pdf\/28\/2\/119\/50193576\/pxac107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:27:10Z","timestamp":1683174430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pch\/article\/28\/2\/119\/7151111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,5,4]]},"published-print":{"date-parts":[[2023,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/pch\/pxac107","relation":{},"ISSN":["1205-7088","1918-1485"],"issn-type":[{"value":"1205-7088","type":"print"},{"value":"1918-1485","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2023,5,1]]}}}